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Abstract 
 
Dystrophin is a cytoskeletal protein that confers resistance to the sarcolemma against 
the stress of contraction-relaxation cycles by interacting with cytoskeletal and membrane 
partners.  Apart from several proteins, membrane phospholipids are a partner of the central rod 
domain made up of 24 spectrin-like repeats, separated into sub-domains by four hinges. We 
previously showed that repeats 1 to 3 bind to membrane anionic phospholipids, while repeats 
20 to 24 are not able to do so. We focus here on the phospholipid-binding properties of the 
major part of the central rod domain, namely the sub-domain delineated by hinges 2 and 3 
comprising 16 repeats ranging from repeat 4 to 19 (R4-19). We designed and produced 
multirepeat proteins comprising three to five repeats and report their lipid-binding properties 
as well as their thermal stabilities. When these proteins are mixed with liposomes including 
the anionic lipid phosphatidylserine, they form stable protein-vesicle complexes as determined 
by gel filtration chromatography. The absence of an anionic lipid precludes the formation of 
such complexes. Spectroscopic analyses by circular dichroism and tryptophan fluorescence 
show that, while the alpha helical secondary structures are not modified by the binding, 
protein trans-conformation leads to the movement of tryptophan residues into more 
hydrophobic environments. In addition, the decrease in the molar ellipticity ratio at 
222/208 nm as observed by circular dichroism indicates that lipid-binding reduces the inter-
helical interactions of multirepeat proteins, thus suggesting partly “opened” coiled-coil 
structures. Combining these results with data from our previous studies, we propose a new 
model of the dystrophin molecule lying along the membrane bilayer, in which the two sub-
domains R1-3 and R4-19 interact with lipids and F-actin, while the distal sub-domain R20-24 
does not exhibit any interaction. These lipid-binding domains should thus maintain a structural 
link between cytoskeletal actin and sarcolemma via the membrane phospholipids. 
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Introduction 
 
Dystrophin is a long filamentous protein essential for skeletal muscle function as indicated by the 
lethal pathophysiology associated with its deficiency, namely the Duchenne muscular dystrophy.
1
 Its 
primary function is likely to provide a mechanical reinforcement of the sarcolemma which opposes the 
stress encountered by contraction and elongation of the muscle fibres at work.
2
 For this purpose, it 
appears essential that dystrophin should interact with several membrane and cytoskeletal partners. 
Several partners have been identified, including the proteins of the dystrophin-glycoprotein complex 
3
, 
in particular β-dystroglycan 4 which interacts with the Cysteine-rich region of the dystrophin located 
between the stabilizing sub-domain R20-24 of the rod domain and the C-terminal end of the molecule. 
Cytoskeletal actin interacts with the dystrophin molecule via two actin-binding domains, ABD1 and 
ABD2, situated at the N-terminal end and at the centre of the dystrophin rod domain (repeats R11-15) 
respectively.
5; 6
 Membrane anionic phospholipids interact with the repeat 2 of the long central rod 
domain.
7; 8
 Such lipid-binding properties of the rod domain may be essential in providing mechanical 
stability to the sarcolemma, as shown in the case of the spectrin-related cytoskeleton of the 
erythrocyte.
9
 Additionally, we previously showed that the sub-domain R1-3 consists in a first lipid-
binding domain (LBD1) exhibiting strong interaction with anionic phospholipids, while the sub-
domain R20-24 exhibits no interaction.
10
 This modularity in the lipid and actin binding properties 
appears essential for the coordination of the function of dystrophin. However, a large part of the 
central rod domain has no known partner. Therefore, it is of great interest to map the entire rod domain 
for its potential lipid-binding properties. Such an investigation was previously carried out for the α- 
and β-spectrin of the erythrocyte,11 where the authors chose to produce recombinant single-repeat 
proteins. Their mapping shows that three patches of three repeats interact with lipids. Early attempts 
by other authors to produce dystrophin single repeats were largely unsuccessful 
12; 13
, and it appears 
that each repeat needs to be extended by several residues at both N- and C-terminal ends to obtain 
properly folded polypeptides. That was also our experience with repeat 23, as reported previously.
10
 In 
the present study, we adopt an alternative strategy that enables us to produce several recombinant 
proteins comprising at least three repeats each. We report here the lipid-binding properties of these 
proteins as well as their thermal stability. Our results combined with previous studies allow us to build 
an overall model of lipid-binding sites within the dystrophin rod domain.  
 
Results 
 
Design and characterization of recombinant dystrophin rod domain constructs 
 
To map the lipid-binding properties of the region R4-9 of the dystrophin rod domain between 
hinges 2 and 3, we first attempted to produce three-repeat long proteins as shown in Table 1 and Fig. 
1. The two first (R4-6 and R7-9), along with one in the centre (R12-14) and the last one (R17-19), 
were successfully expressed, produced and purified in sufficient amounts to obtain biochemical data. 
After concentration and two-step purification, all proteins appeared in Coomassie blue stained 12% 
polyacrylamide gels as bands at apparent molecular weights close to the theoretical values (37 to 39 
kDa). Protein R9-11 was difficult to obtain in sufficient amounts and at the same purity as the others, 
even after ion-exchange chromatography, and was moreover unstable at 4°C. Protein R14-16 was 
obtained at very high purity, but in low amounts. We were repeatedly hindered by the disappearance 
of these two latter proteins during gel filtration chromatography. Therefore, to analyse the regions 
covering these repeats, we cloned other combinations of repeats. We successfully obtained low 
amounts of the three-repeat protein R10-12 and larger amounts of the four-repeat protein R14-17, the 
latter being designed with the same N-terminal short boundary as for R14-16. To analyse the lipid-
binding properties of the actin-binding domain ABD2,
6
 a five-repeat R11-15 was produced with no 
extensions. 
Far UV circular dichroism spectra display the typical features of proteins with a predominant 
α-helix folding, with two well-defined minima, at 208 and 222 nm (Fig. 2, insets), as expected for 
dystrophin repeats 
13; 14
 as well as for spectrin repeats.
15; 16
 The α-helix contents estimated from the 
molar ellipticity values at 222 nm are above 57 % for the three-repeat proteins R4-6, R7-9, R12-14 
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and R17-19, while R10-12 and R14-16 display very low α-helix contents of 20 and 25 %, 
respectively. R14-17 and R11-15, which have four and five repeats, display high α-helix contents at 
66 and 71 %, respectively. It is noteworthy that, for the first 156 residues of the human erythroid α-
spectrin, a large discrepancy was previously observed 
17
 between the α-helix percentages obtained 
from CD at 222 nm (using the common value of -36000 deg.cm
2
.dmol
-1
 for 100% helicity) compared 
with the more accurate results from NMR. The helicity obtained from CD is underestimated by a 
factor of 1.30 compared to NMR. Therefore, it is likely that the proteins studied here may have helical 
contents higher than the values calculated from CD measurements. However, even if we apply the 
ratio obtained previously 
17
 to the very low values obtained for R10-12 and R14-16, the values would 
be 26 and 33% compared to 20 and 25%, respectively. This implies that these two proteins have a 67 
to 74% disordered structure, and thus cannot be considered as well-folded proteins. 
In far-UV circular dichroism spectra, the ratio of the molar ellipticities at 222 nm and 208 nm 
(θ222/θ208) has been used to evaluate the presence of an inter-helix association.18 In particular, the n-π* 
transition at 222 nm is responsive to the α-helical content, while the π-π* excitation at 208 nm is 
sensitive to the helix axis and, therefore, to whether the α-helix axis is interacting with another helix 
as in two-stranded coiled-coils. Thus, the molar ellipticity at 222 nm remains unchanged during an 
inter-helix interaction,  while a decrease is observed in the molar ellipticity at 208 nm.
18; 19; 20; 21
 Zhou 
et al. 
22
 determined empirically that the θ222/θ208 ratio is equal or higher than 1 for two-stranded coiled-
coils, whereas, for non-interacting helices, the ratio is lower than 1, lying between 0.8 – 0.9. In our 
study, the θ222/θ208 ratios range from 1.02 to 1.15 for the six well-folded proteins (Fig.3), strongly 
indicating that the helices of the proteins are associated together in coiled-coils. Therefore, as 
dystrophin and spectrin repeats are exclusively folded in an α-helix, we find that six (R4-6, R7-9, 
R11-15, R12-14, R14-17 and R17-19) out of the eight analysed proteins with α-helical contents higher 
than 50% can be considered as properly folded in an α-helix and structured in coiled-coils. However, 
R10-12 and R14-16 do not satisfy the first condition and therefore do not have a coiled-coil structure. 
Hence, these two latter proteins are not studied in more detail here, and the present investigation of 
stability and potential lipid-binding properties is focused solely on the six properly folded proteins 
covering the entire rod domain comprised between hinges 2 and 3, except for repeat 10. 
  
 
Heat-induced unfolding of multirepeat dystrophin proteins 
 
The heat-induced unfolding was monitored by far UV circular dichroism at 222 nm, with 
proteins being exposed to increasing temperature from 15 to 85°C. Figure 2 presents the results of 
heating expressed as fraction unfolded. Each solid curve represents the best fit of the experimental 
data in relation to Eq. 1, which describes the temperature-unfolding as a two–state process (Materials 
and methods). All the proteins show a two–state unfolding experimental profile, and the calculated Tm 
values are reported in Fig.2. We can observe considerable differences in the sharpness of transitions. 
R7-9 shows a very broad thermal profile while by contrast R14-17 shows a very well defined 
transition. All the Tm values appear to fall within a range from 50 to 65°C. The protein refolding 
capacity upon cooling after heating was tested by heating proteins with a ramp from 15°C to a 
temperature seven degrees higher than the Tm observed in the first data set. The two corresponding 
spectra are shown for each protein in Fig. 2 insets. The proteins refold only partially after heating, with 
the four- and five-repeat R14-17 and R11-15 refolding to a lesser extent than the three-repeat R4-6, 
R7-9 and R12-14. Thus, it appears that the six properly folded proteins are relatively stable, with mid-
denaturation temperatures in the range of 50 to 65°C.  
 
Rod domain proteins bind to anionic phospholipid vesicles and form stable protein-lipid 
complexes  
 
The lipid binding properties of the multirepeat proteins are first assessed using either size 
exclusion chromatography or velocity sedimentation on sucrose density gradients of proteins with or 
without vesicles, to separate physically the protein-vesicle complexes from free protein. Fig. 4 shows 
two examples of the two methods.  
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Firstly, R7-9 and R17-19 are subjected to velocity sedimentation on sucrose density gradients, 
and the different fractions obtained are analysed with SDS-PAGE and Coomassie blue staining (Fig. 
4A). While we observe a peak broadening due to diffusion in the sucrose gradient, the proteins  
sediment out alone as single peaks with maxima in the top fractions of the gradient (15 to 17). These 
fractions correspond to apparent sedimentation coefficients of ~2 S, which fit well with the monomeric 
state of the proteins. The vesicles alone remain on the top of the gradient, as determined by 
spectrometry at 345 nm. Protein-vesicle complexes are detected as single peaks, with maxima in the 
bottom fractions of the gradient (3-7 or 9-13), yielding apparent sedimentation coefficients of 7 to 
10 S. Figure 4A shows that both R7-9 and R17-19 peak at the bottom of the gradient as protein-vesicle 
complexes, when they have been in contact with DOPC/DOPS vesicles, and in the top fractions of the 
gradient when they have been in contact with DOPC/DOPE vesicles. Therefore, we conclude that both 
proteins bind to PC/PS but not to PC/PE.  
Secondly (Fig. 4B), we analysed protein binding to lipid vesicles by size exclusion 
chromatography. Figure 4B shows the results of representative experiments for R4-6 and R11-15. As 
determined by spectroscopy at 345 and 280 nm, vesicles alone are eluted in the 8 ml exclusion volume 
of the column. Proteins alone are eluted in volumes corresponding to proteins with Stokes’ radii of 3.5 
and 4.1 nm for R4-6 and R11-15, respectively; these values fit well with monomeric forms of both 
proteins. When R4-6 or R11-15 are co-incubated in the presence of DOPC/DOPS vesicles prior to 
chromatography analysis, they are found in the exclusion volume, indicating the formation of protein-
vesicle complexes. No such complexes are found when using DOPC/DOPE vesicles. Thus, we 
conclude that these proteins bind to PC/PS and not to PC/PE vesicles. Exclusion chromatography was 
also used to study the potential binding of R12-14 and R14-17 to vesicles, showing that both proteins 
bind to DOPC/DOPS vesicles and not to DOPC/DOPE vesicles (not shown). 
In all cases, we carried out SDS-PAGE of the protein/vesicles mixtures after two hours of 
contact even when the complexes were separated by one or the other method. This shows that there is 
no degradation-proteolysis of the proteins upon binding.  
These results clearly demonstrate that repeats 4 to 19 (except repeat 10, which is not included 
in a construct) of the dystrophin rod domain bind to DOPC/DOPS vesicles, thus inducing the 
formation of stable protein-lipid complexes. As the presence of anionic phospholipid PS is required, 
this indicates that the protein-lipid complexes are formed at least via the action of electrostatic forces. 
Since no negative result is obtained, we should bear in mind that, according to a previous study,
10
 R1-
3 can also form stable lipid-protein complexes while, the R20-24 sub-domain does not bind to any 
type of vesicles and thus could be considered as a negative control for such experiments.  
 
Tryptophan residues are involved in protein-lipid complex formation 
 
Intrinsic tryptophan fluorescence is sensitive to the lipid environment, and binding to lipid 
vesicles induces an increase in fluorescence intensity with or without a blue shift of the emission 
maximum wavelength. These features have been previously reported for the first part of the dystrophin 
rod domain, the sub-domain R1-3.
8; 10
 In the present study, the tryptophan fluorescence spectra of R4-
6, R7-9, R11-15, R12-14, R14-17 and R17-19 are modified by the presence of DOPC/DOPS vesicles, 
while they remain unmodified or only very slightly modified in the presence of DOPC/DOPE vesicles 
(Fig. 5). The fluorescence intensity is increased by 130-370 %, associated with a shift in fluorescence 
emission maximum wavelength from 1 to 5 nm for four of the proteins. No shift is observed in the 
case of R12-14, while a red shift of 1 nm is reported for R11-15 (Table 2). This implies that there are 
conformational changes of the proteins during their binding to DOPC/DOPS vesicles, while the 
presence of DOPC/DOPE vesicles does not greatly modify the protein conformation except that R11-
15 shows a significant quenching of the fluorescence intensity by about 30% in the presence of 
DOPC/DOPE vesicles. 
These results clearly demonstrate that at least several of the tryptophan residues are placed in a 
modified and likely more hydrophobic environment during binding to anionic vesicles. This indicates 
that, in addition to electrostatic forces, hydrophobic forces are involved in the formation of protein-
lipid complexes. 
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Alpha-helical secondary structure is not affected by protein-lipid binding 
 
Far UV circular dichroism spectra were acquired to monitor a possible α-helix content 
modification associated with binding to DOPC/DOPS vesicles and contact with DOPC/DOPE vesicles 
(not shown). The molar ellipticity at 222 nm decreased slightly, indicating that protein binding to 
anionic vesicles induces a decrease of 3-12% in α-helix content. The presence of DOPC/DOPE 
vesicles does not modify the spectra in any way, except for R11-15 where we note a 5% decrease of α-
helix content. We can infer that the 2D structure of the repeats is maintained upon binding.  
Since the molar ellipticity at 208 nm is sensitive to inter-helix association, the θ222/θ208 ratio 
has been used as a criterion of such an interaction.
18; 19; 22
 In Figure 3, we report the values of this ratio 
for proteins in the absence or presence of vesicles. In the presence of DOPC/DOPS vesicles, the 
θ222/θ208 ratio significantly decreases for the three-repeat proteins, R4-6, R7-9, R12-14 and R17-19, 
while it is not significantly modified for the four- and five-repeat proteins, R11-15 and R14-17. 
However, the θ222/θ208 ratio remains higher than 1 for R4-6 (which is the value expected for interacting 
helices in coiled-coils 
22
), while it decreases to values lower than 1 for the other proteins, remaining 
equal to or higher than 0.90 (the values expected for non-interacting helices fall in the range 0.8–0.9). 
In the presence of DOPC/DOPE vesicles, the θ222/θ208 ratio is only lowered by a non-significant 
amount, with all the values remaining higher than 1 except for R7-9 where the value falls significantly 
to 0.92. Therefore, we may conclude that, in the four three-repeat proteins, the inter-helix association 
is decreased upon binding to DOPC/DOPS vesicles, while this is not the case when they are in the 
presence of PC/PE vesicles.  By contrast, in the two four- and five-repeat proteins, R11-15 and R14-
17, the inter-helix association in coiled-coils is not apparently modified by binding to PC/PS vesicles. 
In conclusion, it appears that the 2D structure of the proteins is unmodified by binding to 
anionic lipids, while the 3D structure in coiled-coils is modified in the shorter proteins but not in the 
longer proteins. 
 
 
 
Discussion 
 
The main conclusion of our study is that the rod domain of dystrophin including repeat 4 to 19 
is able to bind strongly to lipid anionic vesicles, thus making up a second lipid-binding domain LBD2. 
The binding does not greatly modify the secondary structure of the proteins and involves electrostatic 
as well as hydrophobic forces.  
Three repeat constructs were first expressed, and the proteins were then purified. The 
theoretical boundaries of each of the 24 dystrophin repeats have long been established by comparison 
with spectrin chains,
23; 24
 and it is clear that they are arranged in coiled-coils with a heptad pattern of 
the primary sequence.
25
 However, experimental data have shown that, in contrast to spectrin repeats,
26; 
27
 it is impossible to express and obtain well-folded single repeats of dystrophin.
10; 12; 13; 14
 It is 
necessary to extend the constructs by several residues on both sides to obtain stable proteins. Such 
extensions are difficult to define optimally. Therefore, in our study, three-repeat proteins are produced 
with extensions at both N- and C-terminal ends by 7 to 9 residues when possible, by assuming a 
Winder-type alignment.
24
 Even with this approach, the central part of the rod domain from repeat 8 to 
16 proves to be extremely difficult to produce in vitro and certain combinations of repeats remain 
impossible to express in high amounts or as well-folded proteins. It is noteworthy that these 
multirepeat proteins contain one of the three repeats lacking tryptophan residues i.e. repeats 10, 11 and 
14. In particular, two conserved Trp residues situated at the 17
th
 and 90
th
 places in repeats are involved 
in spectrin repeat stability. The absence or the mutagenesis of these residues in the spectrin repeat is 
accompanied by a very low stability 
28; 29
 as well as a modification of the 3D structure 
30
 compared to 
repeats containing the two Trp residues. It is likely that folding could be precluded by the presence of 
Trp lacking repeats in several of our constructs. However, R12-14 and R11-15 are well folded even 
though they contain Trp lacking repeats, so other parameters appear to be important in controlling the 
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folding of these proteins. Moreover, we know that repeats 11, 13, 15 and 17 display theoretical 
isoelectric points higher than 7 compared to the others, which all have an isoelectric point lower than 
7. These features merit further experimental investigation. 
 
The mid-transition temperatures of the proteins analyzed here are situated between 50 and 
65°C, falling in the same range as reported in previous studies on dystrophin repeats 
14; 31; 32; 33
 giving a 
minimum of 45°C and a maximum of 69°C. The sub-domains containing repeats 1 to 3 and 20 to 24 
yield Tm values of 50 and 62°C, respectively,
10
 while the single repeat 23 has a Tm of 66°C. It is 
striking that the range of mid-transition temperatures of dystrophin repeats is small compared to the 
erythrocyte and brain spectrin repeats. Some authors have reported stabilities of spectrin repeats 
ranging from 31°C to 63°C,
34
 while others give mid-transition temperatures lower than 37°C and as 
high as 72°C.
26; 27
 However, the Tm of spectrin multirepeat proteins are systematically and significantly 
increased compared to the values for single repeats, showing that there is a cooperative stabilization of 
the structure.
15; 29
 In our study, the four- and five-repeat R14-17 and R11-15 proteins do not display 
significantly higher Tm than the three repeat proteins. This agrees with our previous observations about 
R1-3 and R20-24 compared to single repeats R2 and R23.
10
 Taking into account a previous study 
using two-repeat constructs of dystrophin,
33
 it appears that our three-repeat constructs are not more 
stable than their two-repeat counterparts. All these results demonstrate that dystrophin repeats can be 
distinguished from spectrin repeats by their higher and more homogeneous stability properties 
compared to the large range of spectrin repeat stability.  
 
The lipid-binding property of dystrophin rod domain was first proposed in 1997 by DeWolf in 
Gratzer’s group 
7
 and subsequently by our group,
8
 by  showing that repeat 2 binds specifically to 
anionic phospholipids. We then started a systematic study of the entire rod domain, recently showing 
that the sub-domain comprising the repeats 1 to 3 binds to anionic phospholipids while the sub-domain 
comprising repeats 20 to 24 does not. This highlights the fact that the repeats of dystrophin have 
distinct properties and likely play distinct roles in the muscle cell. Here, we supplement the qualitative 
study and show that anionic lipids bind strongly with the sub-domain comprising repeats 4-19. We use 
the same approach as used previously to unify the results in terms of lipid model. SUVs have been 
extensively characterized as highly curved vesicles with a high surface pressure compared to larger 
vesicles such as large or giant unilamellar vesicles.
35
 In a quantitative description of repeat 2 lipid-
binding properties, we have shown that the repeat binds very weakly to LUVs compared to SUVs, 
except when LUVs contain PE and/or cholesterol. This evidence argues for the repeat 2 binding being 
influenced by lipid packing rather than curvature. 
36
 The biochemical methods used here allow the 
physical separation of vesicles from free proteins. Therefore, it is clear that stable PC/PS-protein 
complexes are formed with significant affinity. The binding does not induce any protein hydrolysis 
after two hours of contact, which corroborates the formation of stable protein-lipid complexes. While 
we have not explicitly measured the association constants of the binding process,  the ratios between 
protein and vesicle phospholipids are similar to the ratios previously used 
8; 36
 and lead to a binding of 
more than 90 % of the proteins.  
Tryptophan fluorescence has long been used to study the conformation of proteins and 
monitor changes of the tryptophan environment associated with binding to a number of ligands 
including lipids. The intrinsic tryptophan fluorescence is quenched in folded proteins by several 
mechanisms, including excited-state electron transfer from the indole ring to amino-acid side chains, 
in particular glutamine, asparagine, glutamic and aspartic acids, as well as cysteine and histidine
37
. 
Electron transfer also occurs towards the peptide bond.
38
  The proximity and geometry of the indole 
ring in relation to the surrounding side chains can suppress or enhance tryptophan quenching, and 
therefore modify fluorescence quantum yield (and hence intensity) as well as maximum emission 
wavelength. However, tryptophan has a preference for membrane interfaces,
39; 40
 where the indole ring 
can accommodate with the phospholipid glycerol backbone. Under such conditions of lipid proximity 
and folding modification, the fluorescence emission shows an increase in quantum yield and intensity, 
as well as a shift of maximum wavelength towards the blue end of the spectrum. The fluorescence 
intensity of the studied proteins is largely modified in the presence of anionic phospholipid vesicles, 
while the maximum emission wavelength is slightly shifted to the blue end in four of these proteins, as 
previously observed with repeat 2
8
 and sub-domain R1-3.
10
 The two longest proteins show no blue 
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shift or a small red shift of the maximum emission wavelength, possibly due to large environmental 
changes that could enhance or decrease quenching of the numerous tryptophan residues via the 
surrounding side chains. Overall, these results indicate that at least one or several tryptophan residues 
in proteins are less quenched. In this way, they are concomitantly placed into a more hydrophobic 
environment as expected during lipid binding. Indeed, there is more than one tryptophan residue per 
protein, and we cannot assign a lipid-binding property to any one of them specifically. Moreover, far 
UV circular dichroism at 222 nm shows only a slight decrease of the protein α-helix content, 
indicating that the overall secondary structure of the repeats is maintained in the protein-lipid 
complexes. However, even though the 2D structure in α-helix is not modified, the molar ellipticity at 
208 nm - and therefore the θ222/θ208 ratio as well - are significantly decreased upon lipid-binding of the 
four three-repeat proteins. This decrease in values upon lipid-binding indicates a lower degree of inter-
helix interaction,
18; 22
 leading to the idea that coiled-coils open when binding to lipids. However, the 
ratio does not reach the values of 0.8-0.9 observed in proteins in the presence of TFE, when there is 
complete disruption of the inter-helix association.
20; 21
 Therefore, it appears that the coiled-coils only 
open partly upon lipid binding. This implies that only some of the nine helices present in the three-
repeat proteins no longer interact to form coiled-coils. The fact that the large proteins, R11-15 and 
R14-17 fail to show any apparent modification of the θ222/θ208 ratio may suggest they are not modified 
upon binding to anionic lipids. However, there are insufficient examples of the use of CD at 208 and 
222 nm of proteins upon lipid binding in solution, so we cannot infer the absence of trans-
conformation of these proteins. With such large proteins, it may be more complex to carry out the 
analysis of CD spectra. Other factors may contribute to the overall values of CD at 208 and 222 nm, 
hence  precluding the use of the ratio to monitor inter-helical interactions in such large proteins. 
Hence, we tentatively conclude that binding of the proteins to anionic lipids initially occurs 
via an electrostatic force which, in turn, induces a trans-conformation; this trans-conformation results 
in a partial opening of the 3D coiled-coil structure, which allows the transfer of some of the Trp into a 
more hydrophobic environment. At present, we have no grasp of the molecular/structural mechanism 
by which the helices could “open” during lipid-binding. There is currently no available structural data 
on any dystrophin repeat. We performed molecular modelling of the wild type and mutated repeat 23, 
showing that the coiled-coil is a very good model for this repeat.
41
 
 
No protein-lipid complexes could be detected by biochemical methods following contact of 
the proteins with PC/PE vesicles; however, the fluorescence spectrum of R11-15 is systematically 
quenched by about 30% in the presence of such vesicles, which represents a notably large 
modification. This could be interpreted as due to a weak interaction with PC/PE, which precludes the 
formation of sufficiently stable protein-lipid complexes to be recovered during exclusion 
chromatography. It is noteworthy that R11-15 has actin-binding properties 
6
 in addition to the lipid-
binding properties shown here. Therefore, it is tempting to consider that this protein has specific 
biochemical properties. This point deserves to be investigated by further experiments.  
 
Numerous studies have been carried out on the lipid-binding properties of spectrin repeats, 
giving rise to an extensive review by Sikorski et al.. 
42
 The binding properties of PS as well as PE 
vesicles with spectrin repeats are reported in the literature, in contrast to our studies where we failed to 
demonstrate any significant PE binding of dystrophin repeats, except for a weak binding of R11-15 to 
PC/PE observed by fluorescence spectroscopy. Considering the lipid-binding properties of dystrophin 
repeats, this is a first significant difference between the two proteins of the same family. Moreover, in 
erythrocyte and brain α-and β-spectrin, anionic-lipid binding repeats are concentrated in clusters of 
two/three repeats.
11; 43
 By contrast, we find evidence for one cluster of non-lipid-binding repeats, i.e. 
repeat 20-24, as shown in an earlier study.
10
 This is a second significant difference between the lipid-
binding properties of dystrophin compared to spectrin. However, since we did not produce single 
repeats, we cannot rule out the hypothesis of one or several repeats which do not bind to phospholipids 
as such but are included in larger regions binding to lipids. Considering that R4-6 and R7-9 have no 
overlapping regions, a yet unknown part of each of these proteins may interact with lipids. R11-15, 
R12-14 and R14-17 have the repeat 14 in common; however, since this repeat does not contain any 
tryptophan residue, fluorescence can only be due to one or several of the other repeats. While repeat 
11 does not contain any tryptophan residue, such interactions might concern repeats 12, 13 and 17. 
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Therefore, it seems that an unknown part of these repeats is able to interact with lipids in the region 
from repeat 11 to 15. For the region R14-17, the repeat 17 is common with R17-19, so we cannot rule 
out the possibility that only repeat 17 can bind to lipids. However, we should note that, even in single 
spectrin repeats, there is so far no experimental evidence of specific residues interacting with lipids. 
The specific lipid-binding sites are able to position the multi-repeat proteins very near the vesicles, 
thus allowing the formation of stable lipid-protein complexes.  
Even though there are broad similarities between the primary sequences of spectrin and 
dystrophin, as well as in the overall arrangement of the molecules, there are significant differences that 
could be assigned to different biological functions of the two molecules. As a whole, dystrophin 
repeats are more stable than the spectrin repeats. It is noteworthy that the lipid-binding spectrin repeats 
are among the least stable. Erythrocyte and brain spectrin repeats with lipid-binding properties display 
Tm below 50°C
26
 and 40°C,
27
 respectively. This is not the case for dystrophin repeats, where the rod 
domain repeats 1 to 19 bind to phospholipids and display Tm values distributed over the small range of 
50 to 65°C. The most important difference between spectrin and dystrophin is that spectrin chains 
make up α/β dimers which in turn form a tetramer.  Such a process has never been shown for the 
dystrophin molecule. It is likely that the dimerization property of spectrin could be involved in such 
differences. 
Taking into account all these results, we propose to assign two lipid-binding domains for dystrophin 
(Fig.6A). The lipid-binding domain 1 (LBD1) comprises the well defined region R1-3 as reported 
previously,
10
 while the lipid-binding domain 2 (LBD2) comprises the central rod domain R4-19 as 
shown here. The region R11-15 makes up the 2
nd
 actin-binding domain of dystrophin 
6; 44
 and we show 
here that it also binds to membrane phospholipids. It remains to be elucidated whether these two 
binding properties play a simultaneous role or are competitive. However, by these interactions, it is 
evident that the dystrophin molecule is situated very near the sarcolemma, with a large part of the rod 
domain lying along the lipid bilayer as illustrated in Fig. 6B. The biological relevance of such domain 
studies is a fundamental question. The lipid-binding properties of intact dystrophin have so far not 
been investigated, essentially because dystrophin is a heavy protein that can be more readily studied in 
terms of specific domains rather than as a whole. However, since dystrophin is a filamentous protein 
with more than 75% of its structure made up of a linear chain of repeats, we can assume that the series 
of several repeats studied here are representative of the whole molecule. 
 
When dystrophin is absent from muscle, the sarcolemma is very frequently disrupted 
45; 46; 47
 
and a higher susceptibility to eccentric contractions is observed 
48; 49; 50
 leading to a high number of 
leaky muscle fibres. Accordingly, immobilization of dystrophin-deficient muscle is accompanied by 
markedly reduced signs of dystrophy.
51; 52; 53
 These observations clearly indicate that dystrophin is 
involved in the mechanical resistance against the stress induced by the contraction-relaxation cycles of 
active muscle. Through interactions with cytoskeletal actin, the dystrophin-glycoprotein complex 
proteins and membrane phospholipids, dystrophin acts as a physical link between cytoskeleton and 
extracellular matrix which could behave as a “shock absorber” dampening elastic extension during 
muscle stretching.
54; 55
 This role could involve interaction of the dystrophin molecule with the 
cytoskeletal γ-actin. A second molecular aspect of this mechanical function could be related to the 
intrinsic properties of the lipid bilayer. The cohesion of the cellular lipid bilayer is ensured by its 
association with cytoskeleton proteins, which provide it with a “solid support”.
56; 57
 Thus, by 
interacting with phospholipids, specialized cytoskeleton proteins are able to maintain the cohesion of 
the lipid molecules during compression and re-extension of the membrane. Such proteins are 
associated, for example, with pulmonary surfactant,
58
 and spectrin plays such a role in red blood 
cells.
9; 59
 In muscle cells, this role as a “solid support” could be played by dystrophin molecule by its 
interaction with the lipid bilayer.  
Our results show that the major part of the dystrophin rod domain binds to membrane lipids, 
which offers new avenues for investigating the comprehensive role of dystrophin in the muscle cell 
and a new basis for understanding the molecular genesis of the pathology induced by dystrophin 
deficiency. 
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Reagents 
 
All lipids were obtained from Avanti Polar Lipids (Alabama, US), and were used without further 
purification. The pGEX-4T1 plasmid vector, GST-Trap
TM
 HP column and HiTrap
TM
 columns were 
purchased from GE Healthcare, while restriction enzymes were supplied by Ozyme (St Quentin-en-
Yvelines, France) and Promega (Charbonnières, France). The IMPACT™ kit (Intein Mediated 
Purification with an Affinity Chitin-binding Tag),  including the pTYB1 vector, chitin beads and E. coli 
host strain ER2566, was purchased from Ozyme. 
 
Cloning 
 
The plasmid pTG11025 harbouring the cDNA for the Dp427m muscle isoform of human 
dystrophin (NCBI Nucleotide Data base NM-004006, provided by S. Braun Transgene, France) was 
used as a template for PCR amplification of fragments encoding three-repeat proteins (R4-6 to R17-19) 
and one four-repeat protein (R14-17) of the dystrophin rod domain, as shown in Fig. 1A. Small 
extensions of 7-9 amino acid residues were added at both N- and C-termini of multi-repeat proteins to 
improve stability of the coiled-coil motifs (Table 1), as recommended previously,
12
 except for the 
repeats adjacent to hinges (R4 and R19). R14-16 and R14-17 were extended by two residues only at the 
N-terminus to avoid the presence of a helix-breaker proline residue at the beginning of the protein 
sequence. Table 1 gives the exact boundaries of the multi-repeat proteins. To avoid further small amino-
acid extensions of the recombinant proteins arising from cleavage of the fusion proteins, PCR were 
amplified with 5’ primers containing the Nde I restriction site and 3’ primers with half parts 
corresponding to the eighteen first bases of the intein sequence of the pTYB1 vector from TGCTTT up 
to the Kpn I restriction site. In this way, cloning of such PCR products into pTYB1 using the Nde I and 
Kpn I restriction sites allowed suppression of the MCS and expression of the dystrophin rod fragments 
directly fused with the full intein tag at the C-terminus. 
The cDNA encoding R11-15, similar to the actin-binding domain situated in the rod domain,
6
 
was cloned into pGEX-4T1 downstream of the sequence of Glutathione S-transferase (GST) using Bam 
HI and Xho I restriction sites. The boundaries of R11-15 were chosen without any extension based on 
the alignment of spectrin triple helical repeats of dystrophin.
24
 
All the PCR amplified products were checked by a Big Dye terminator sequencing procedure.  
 
Protein expression and purification 
 
Proteins were expressed in the protease-deficient Escherichia coli ER2566 strain as proteins 
tagged by GST or intein-chitin binding domain (Intein-CBD), and then purified by affinity 
chromatography followed by ion-exchange chromatography. Cultures were grown to an absorbance at 
600 nm of 0.6-0.8 at 37°C in LB supplemented with 100 µg.mL
-1
 ampicillin, and then induced to 
express intein-CDB fusion proteins with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) at 25°C 
overnight or GST-R11-15 protein with 1 mM IPTG for 4 hours at 37°C. After harvesting, bacterial 
pellets were resuspended in ice-cold column buffer (20 mM Tris-HCl, 150 mM NaCl, pH 7.5), subjected 
to sonication on ice ten times for 30 s and then clarified by centrifugation at 13,000 g. 
GST-R11-15 protein was purified on a GST-Trap
TM
 HP column and released after enzymatic 
cleavage with thrombin as previously described for R1-3.
10
 Intein-CBD tagged proteins were loaded 
onto a pre-equilibrated chitin column (5 mL) at 0.5 mL.min
-1
. After washing with column buffer, the 
column was quickly flushed with cleavage buffer (20 mM Tris-HCl, 150 mM NaCl, DTT 50 mM pH 
7.5), and then on-column cleavage took place for 48 hours at 4°C. Elution was performed in the column 
buffer. In cases where proteins needed further purification, ion exchange chromatography was 
performed on 1mL HiTrap
TM
 Q column with a NaCl gradient in Tris 20 mM pH 7.5, except for R12-14 
which required HiTrap
TM
 SP. Purified proteins were dialysed extensively against TNE buffer (20 mM 
Tris-HCl, 150 mM NaCl, 0.1 mM EDTA, pH 7.5), concentrated and quantified using the BCA 
(bicinchoninic acid) protein assay.  
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Phospholipid vesicle preparations 
 
Multilamellar vesicles were first prepared. Mixtures containing two parts of DOPC and one part 
DOPS or DOPE in chloroform were dried overnight under vacuum and suspended in TNE buffer. Small 
unilamellar vesicles (SUV) were prepared from MLV diluted at 25 mg.mL
-1
 and sonicated at room 
temperature with the micro-tip of a sonicator for 1 min with half-duty cycles. The SUVs were then 
centrifuged at 20 000 g to eliminate titanium impurities. The SUV sizes determined by dynamic light 
scattering (4700/PCS100 Malvern) were about 50-60 nm for DOPC/DOPS and DOPC/DOPE lipid 
mixtures. Oxidation products were not detected in the SUVs obtained by sonication.
36
 
 
Separation of protein-lipid complexes from free protein 
 
To separate free protein from vesicles with or without bound protein, gel-filtration 
chromatography or velocity sedimentation on sucrose density gradient were performed with dystrophin 
sub-domains or vesicles alone and with vesicles/protein mixtures. Gel-filtration chromatography was 
performed on a Sephacryl S-200 column (10 x 300 mm). The column was loaded with 100-µL samples 
of i) proteins alone at 5µM, ii) DOPC/DOPS or DOPC/DOPE SUVs alone (5 mM) or iii) protein/SUVs 
mixtures (1/1000, M/M). The column was eluted at 10°C with TNE buffer at a flow rate of 0.5 mL.min
-1
 
and fractions of 1 mL were collected. The standard proteins used for column calibration were alcohol 
deshydrogenase (Rs = 4.6 nm), bovine serum albumin (Rs = 3.5 nm), ovalbumin (Rs = 2.7 nm) and 
cytochrome c (Rs = 1.7 nm). Elution was monitored by recording the absorbance at 280 nm for proteins 
and at 345 nm for vesicles. The fractions corresponding to the exclusion volume of the column and the 
elution volumes of single proteins were analysed by SDS-PAGE followed by silver staining.  
For velocity sedimentation, we used 5 mL linear 2-20% (w/v) sucrose density gradients prepared 
from sucrose stock solutions in TNE buffer. 100 µL of proteins, vesicles or vesicle-protein mixtures 
were layered on top of the gradient and ultracentrifugation was performed at 100,000 g for 16 h at 4°C. 
Calibration curves for the determination of the apparent sedimentation coefficient were constructed 
using cytochrome C (S20,w = 1.7 S), bovine serum albumin (S20,w = 4.3 S) and IgG (S20,w = 7 S). 
Following centrifugation, 21 fractions were collected from the bottom of each gradient. Absorbance at 
345 nm was used for detection of vesicles. SDS-PAGE followed by Coomassie Blue staining was used 
for protein detection. 
 
Far UV circular dichroism spectropolarimetry 
 
Far UV circular dichroism spectra were recorded on a Jasco J-815 spectropolarimeter (Jobin-
Yvon, Nantes, France) under N2 atmosphere at 20°C using a path length of 0.2 cm in a quartz cell with 
two-three accumulations. Blanks corresponding to buffer or SUVs alone were subtracted from the 
spectra. The molar ellipticity at 222 nm was calculated using the mean residue molar concentration of 
the proteins and the percentage of α-helix was obtained using a 100% α-helix value of -36000 
deg.cm
2
.dmol
-1
 at 222 nm.
60
 The heat-induced unfolding was monitored by CD at 222 nm with protein 
concentrations of about 2.5 µM in TNE buffer, increasing temperature in increments of 1 deg/min from 
15 to 85°C using a Peltier device, with temperature equilibration steps of 30 s. To determine to what 
extent thermal unfolding is reversible upon cooling, a second set of data was obtained for each protein 
by heating to about 7 degrees above the melting temperature observed in the first set of data, i.e. from 15 
to 85°C. The temperature was allowed to return to 15°C very rapidly after reaching the last temperature 
point and the spectrum was acquired at 20°C after 30 min of cooling. 
Circular dichroism signals at 222 nm subtracted from background were fitted to the following equation 
describing unfolding as a two-state thermodynamic process according to Becktel 
61
 and as used 
previously for dystrophin repeat unfolding 
10
:   
  y = [(αN + βNT + (αD + βDT) exp(-∆H0un + T∆S0un) / RT)] / [1 + exp(-∆H0un + T∆S0un) / RT)] 
(equation 1) 
where y is the value at temperature T, αN and αD are the intercepts of the native and denatured states, 
respectively, βN and βD are the slopes of the native and denatured states, respectively, ∆H0un and ∆S0un are 
the entropy and enthalpy changes for unfolding, respectively, and R is the gas constant in J mol
-1
 K
-1
.  
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Fluorescence spectroscopy 
Tryptophan intrinsic fluorescence spectra were recorded on a Fluorolog 3 spectrofluorometer 
(Jobin-Yvon, Longjumeau, France) at 20°C in a correct mode between 310 nm and 420 nm (bandwidth, 
5 nm) with an excitation wavelength of 295 nm (bandwidth, 1 nm) in 300 µL using 10 x 10-mm quartz 
cells. Blanks were subtracted using the same experimental conditions (i.e. buffer, SUVs). Fluorescence 
intensities were obtained by integrating the spectra in the range 310-420 nm.  
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Legends to Figures 
 
Fig.1. Schematic representation of the dystrophin domains.  The entire dystrophin molecule with: 
NT, N-terminal domain; C, Cys-rich domain; CT, C-terminal domain; H1 to H4, hinges 1 to 4. White 
boxes represent the 24 repeats of the rod domain. The different multirepeat constructs corresponding to 
the centre of the rod domain are shown.  
 
Fig.2. Heat-induced unfolding measured by circular dichroism. Heat-induced unfolding determined 
by CD at 222 nm with temperature increase from 15 to 85°C. Proteins concentrations are 5 µM in TNE 
buffer at pH 7.5. For each experimental data expressed as % of unfolding (open circles), a solid curve 
represents the best fit related to Eq. 1 describing the temperature-unfolding as a two–state process. Tm is 
calculated as ∆H0un /∆S0un and is indicated on each curve. Insets show the CD spectra of the protein 
before heating (solid lines) and after heating to 7 degrees above the Tm first determined (dashed lines). 
The percentage of α-helix content obtained from CD at 222 nm before heating is indicated on each inset.  
 
Fig.3. Far UV circular dichroism θ222/θ208 ratio of proteins with or without presence of lipid 
vesicles. CD values are determined from proteins in TNE buffer in the absence (black) or presence of 
DOPC/DOPS (light grey) or DOPC/DOPE (dark grey) vesicles. Values are mean ± SD for three 
measurements. The line corresponds to ratio value of 1, which is considered as the lower limit 
empirically used as a criterion of coiled-coil formation. 
 
Fig.4. Lipid-binding of dystrophin multirepeat proteins. Representative data of (A) velocity 
sedimentation on sucrose density gradient and (B) gel-filtration chromatography, showing that proteins 
are recovered as protein-lipid complexes when in contact with DOPC/DOPS vesicles. Protein is placed 
in contact with DOPC/DOPS or DOPC/DOPE vesicles for 2 hours at 20°C. Free protein is separated 
from protein-lipid complexes by one of the two methods. SDS-PAGE followed by Coomassie blue (A) 
or silver staining (B) is performed for protein detection.  
 
Fig. 5. Conformational changes of the multirepeat proteins upon binding to lipid vesicles 
monitored by fluorescence. Intrinsic Trp fluorescence corrected spectra of proteins in TNE buffer in 
absence (black circles), or in presence of DOPC/DOPS (white circles) or DOPC/DOPE (white squares) 
vesicles at an excitation wavelength of 295 nm. a. u. (arbitrary units).  
 
 
Fig. 6. Schematic illustration of the lipid-binding domains of dystrophin and a new view of 
dystrophin in the muscle cell. (A) Dystrophin molecule and its identified partners. H1-4, hinges 1 to 4; 
ABD1 and ABD2, actin-binding domains 1 and 2; DGC, dystrophin-glycoprotein complex; LBD1 and 
LBD2, lipid-binding domains 1 and 2; “?” indicates the region of repeats 20-24 with partners that are not 
yet identified. (B) Dystrophin (purple) is represented in the cell context with its different partners 
(yellow). Lipid-binding domains closely attach dystrophin to the sarcolemma by interactions with the 
membrane phospholipids. Actin-binding domains interact with the cytoskeleton via γ-actin and Cys-rich 
domain and C-terminal end interact with β-dystroglycan (β-DG), α-dystrobrevin-2 (α-DB2) and 
syntrophins (SYN). α-DG, α-dystroglycan; SGC/SPN, sarcoglycan / sarcospan complex. 
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Table 1. Dystrophin multirepeat proteins used  
 
 
Construct 
(number of 
residues) 
Start 
residue 
End residue N-terminus C-terminus 
R4-6 (338) 
R7-9 (339) 
R9-11 (323) 
R10-12 (327) 
R11-15 (513)
#
 
R12-14 (323) 
R14-16 (331) 
R14-17 (439) 
R17-19 (329) 
718 
1039 
1257 
1361 
1461 
1562 
1780 
1780 
2095 
1054 
1376 
1578 
1686 
1972 
1883 
2109 
2217 
2422 
 
M*SEIRKR… 
MHCQKLEEQMN… 
MKCKTLEEVWA… 
MRQKLLEQSIQ… 
GSFQKPAN… 
MRKQQLEKCLK… 
M(P)LKELEQF… 
M(P)LKELEQF… 
MRQGRFDRSVE… 
 
…EEQMNKLRKIQ 
…EQSIQSAQETE 
…EKCLKLSRKMRK 
…LEYQKHMETFDQ 
…RLNFAQ 
…LEISHQWYQYK 
… DRSVEKWRRF 
…EEQKNILSEFQ 
…LLQELRA**(KQPDL) 
 
 
*R4-6 starts at the first residue of repeat 4 as there is hinge 2 before. 
**R7-19 ends before the exact end of repeat 19 as there is a Proline residue and the hinge 4 
after.  
Residue in bold indicates the start (N-terminus column) or end (C-terminus column) residue of 
the repeat from the Winder alignment.
24
 
Residue underlined indicates the start (N-terminus column) or end (C-terminus column) residue 
of the repeat from the Koenig alignment;
23
 when missing, it is underlined and in parentheses 
(Residue).  
GS or M in italics indicate the residues left at the N terminus after cleavage of the tags. 
#
 the actin-binding domain described in this region is from residue 1416 – 1880 
6
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 Table 2. Trp fluorescence changes upon binding of proteins to DOPC/DOPS vesicles 
 
Three-repeat 
proteins 
 
Tryptophan residues per 
repeat 
Number of 
tryptophan 
residues per 
protein 
Fluorescence 
maximum 
wavelength (nm) 
without/with 
binding to anionic 
vesicles* 
Fluorescence 
increase on 
binding to anionic 
vesicles 
R4-6 R4 (3), R5 (1),  
R6 (2) 
 
6 334 / 333 
 
180 % 
R7-9 R7 (3), R8 (2),  
R9 (4)  
 
9 337 / 335 130 % 
R11-15 R11 (0), R12 (4), 
R13 (1), R14 (0), 
R15 (2) 
 
7 331 / 330 170 % 
R12-14 R12 (4), R13 (1), 
R14 (0)** 
 
6 333 / 333 370 % 
R14-17 R14 (0), R15 (2), 
R16 (1), R17 (5) 
 
8 334 / 332 130 % 
R17-19 
 
R17 (5), R18 (2), 
R19 (2) 
9 338 / 333 150 % 
The underlined repeats (example, R11, (0)) contain no tryptophan residue.  
*excitation wavelength is 295 nm; spectra were fitted with a Gaussian curve to obtain an 
accurate determination of the maximum emission wavelengths  
**a Trp residue from the 15
th
 repeat is situated in the C-terminal extension of this construct (see 
Table 1) 
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